Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Non-Current Debt (2020 - 2023)

Historic Non-Current Debt for ADC Therapeutics (ADCT) over the last 2 years, with Q4 2022 value amounting to $109.7 million.

  • ADC Therapeutics' Non-Current Debt rose 2588.67% to $109.7 million in Q4 2022 from the same period last year, while for Dec 2022 it was $109.7 million, marking a year-over-year increase of 2588.67%. This contributed to the annual value of $109.7 million for FY2022, which is 2588.67% up from last year.
  • ADC Therapeutics' Non-Current Debt amounted to $109.7 million in Q4 2022, which was up 2588.67% from $87.2 million recorded in Q4 2021.
  • In the past 5 years, ADC Therapeutics' Non-Current Debt registered a high of $109.7 million during Q4 2022, and its lowest value of $87.2 million during Q4 2021.